Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Tranexamic acid

Tranexamic acid

pharmaceutical raw materials
Tranexamic acid structure

Tranexamic acid 

structure
  • CAS No:

    1197-18-8

  • Formula:

    C8H15NO2

  • Chemical Name:

    Tranexamic acid

  • Synonyms:

    Cyclohexanecarboxylic acid,4-(aminomethyl)-,trans-;trans-4-(Aminomethyl)cyclohexanecarboxylic acid;DV 79;AMCHA;Amikapron;trans-p-(Aminomethyl)cyclohexanecarboxylic acid;Tranexamic acid;Transamin;Anvitoff;trans-4-(Aminomethyl)-1-cyclohexanecarboxylic acid;Bay 3517;Cyklokapron;TAMCHA;trans-Amcha;Ugurol;Cyclocapron;Transamin S;Transamin G;trans-Tranexamic acid;AMCA;t-AMCHA;Xamig;Zataranax;Exacyl;CL 65336;Cyclokapron;4-trans-Aminomethylcyclohexanecarboxylic acid;Xed;Tranol;Haematrix;Transcam;HAKU;Amchafibrin;Lysteda;1628783-16-3

  • Categories:

    Cosmetic Ingredient  >  Skin Conditioning

Description

Tranexamic acid (Transamin) is an antifibrinolytic for blocking lysine-binding sites of plasmin and elastase-derived plasminogen fragments with IC50 of 5 mM. Target: OthersTranexamic acid is a synthetic derivative of the amino acid lysine. Tranexamic acid is frequently used in surgeries with high risk of blood loss such as cardiac, liver, vascular and large orthopedic procedures. Its oral form is now being evaluated for use in outpatient conditions involving heavy bleeding.Toxicity/Adver

Tranexamic acid Basic Attributes

157.21

157.21

2207452

214-818-2

2922499990

Characteristics

63.32000

0.31

White Crystalline Powder

1.1±0.1 g/cm3

>300 °C

300.2±15.0 °C at 760 mmHg

135.4±20.4 °C

1.497

H2O: 1g/6ml

Store at 0°C

0mmHg at 25°C

Oral-rat LD50: 3000 mg/kg; Subcutaneous-mouse LD50:5310 mg/kg

Flammable; burning produces toxic nitrogen oxide fumes

Safety Information

II

IRRITANT

UN 1993 3/PG 2

2

36/37/38

26-36-37/39

GU8400000

Xi

Warehouse ventilated, low temperature and dry

Stable at room temperature in closed containers under normal storage and handling conditions.

P305 + P351 + P338

H315-H319-H335

Toxicity

moderately toxic

Tranexamic acid Use and Manufacturing

Fibrinolysis, the cleavage of fibrin by plasmin, is a normal step in the dissolution of fibrin clots after wound repair. Tranexamic acid is an inhibitor of fibrinolysis that blocks the interaction of plasmin with fibrin (IC50 = 3.1 μM). It is a lysine mimetic that binds the lysine binding site in plasmin. Antifibrinolytic agents have value when fibrinolytic activity is abnormally high or when coagulation is impaired.

Drug Function and Efficacy

Tranexamic acid competitively inhibits the adsorption of plasminogen on fibrin, reduces the generation of plasmin, and thus inhibits the degradation of fibrin and prevents bleeding.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • MALLADI DRUGS AND PHARMACEUTICALS LTD

    United States United States
    Active
  • Yantai Valiant Pharmaceutical Co.,Ltd.

    Japan Japan
    Active
  • Cheer Fine Pharmaceutical Co.,Ltd.

    Japan Japan
    Active

Recommended Suppliers of Tranexamic acid

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.